verapamil has been researched along with allopurinol in 54 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 10 (18.52) | 18.7374 |
| 1990's | 26 (48.15) | 18.2507 |
| 2000's | 10 (18.52) | 29.6817 |
| 2010's | 8 (14.81) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Topliss, JG; Yoshida, F | 1 |
| Gao, F; Lombardo, F; Obach, RS; Shalaeva, MY | 1 |
| Benz, RD; Contrera, JF; Kruhlak, NL; Matthews, EJ; Weaver, JL | 1 |
| Lombardo, F; Obach, RS; Waters, NJ | 1 |
| Ahlin, G; Artursson, P; Bergström, CA; Gustavsson, L; Karlsson, J; Larsson, R; Matsson, P; Norinder, U; Pedersen, JM | 1 |
| Chupka, J; El-Kattan, A; Feng, B; Miller, HR; Obach, RS; Troutman, MD; Varma, MV | 1 |
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Chang, G; El-Kattan, A; Miller, HR; Obach, RS; Rotter, C; Steyn, SJ; Troutman, MD; Varma, MV | 1 |
| García-Mera, X; González-Díaz, H; Prado-Prado, FJ | 1 |
| Chen, M; Fang, H; Liu, Z; Shi, Q; Tong, W; Vijay, V | 1 |
| Artursson, P; Haglund, U; Karlgren, M; Kimoto, E; Lai, Y; Norinder, U; Vildhede, A; Wisniewski, JR | 1 |
| Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Jacinto, SM; Jandhyala, BS | 1 |
| Belzer, FO; Kim, SK; Southard, JH | 1 |
| Rocha, AS; Seguro, AC; Yu, L | 1 |
| González, R; Pascual, C; Romay, C | 1 |
| Jin, N; Packer, CS; Rhoades, RA | 1 |
| Ahrén, B; Ar'Rajab, A; Bengmark, S | 1 |
| Adams, GE; Cundall, RB; Hasan, NM | 1 |
| Cheng, S; Deveney, CW; Lee, RG; Pinson, CW; Ragsdale, JR; Sasaki, AW | 1 |
| Adachi, T; Goto, M; Iimura, O; Iwamoto, T; Miura, T; Noto, T; Ogawa, T; Ooiwa, H; Tsuchida, A | 1 |
| Ishii, K; Suita, S; Sumimoto, H | 1 |
| Fryer, PR; Green, CJ; Pickford, MA; Sarathchandra, P | 1 |
| Tiegs, G; Wendel, A; Wolter, M | 1 |
| Denniss, AR; Kingma, JG; Yellon, DM | 1 |
| Athar, M; Bickers, DR; Elmets, CA; Mukhtar, H | 1 |
| Robak, J; Shridi, F | 1 |
| Belzer, FO; Goossens, D; McAnulty, JF; Ploeg, RJ; Southard, JH; Vreugdenhil, P | 1 |
| Burghardt, B; Janero, DR; Lopez, R | 1 |
| Denniss, AR; Downey, JM; Hearse, DJ; Kingma, JG; Yellon, DM | 1 |
| Espnes, KA; Jynge, P; Oksendal, AN | 1 |
| Kolassa, N; Pfleger, K; Volkmer, I | 1 |
| Downey, JM; Hearse, DJ; Yellon, DM | 1 |
| Aktan, AO; Büyükgebiz, O; Yalin, R; Yeğen, C | 1 |
| Dettmer, D; Drews, G; Hauss, J; Hermsdorf, T; Richter, V; Spiegel, HU | 1 |
| Israeli, D; Senderoff, DM; Urken, ML; Weinberg, H; Zhang, WX | 1 |
| Di Giacomo, C; La Delfa, C; Perez-Polo, JR; Renis, M; Russo, A; Sorrenti, V; Vanella, A | 1 |
| Bowers, JL; Clouse, ME; Cook, CU; Neymark, E | 1 |
| Benevento, A; Castoldi, L; Foschi, D; Lesma, A; Musazzi, M; Trabucchi, E | 1 |
| Bertuglia, S; Colantuoni, A; Intaglietta, M | 1 |
| Guttman, FM; Lubin, A; Mayer, SK; Richardson, J; Rosenmann, E; Takara, T; Zorychta, E | 1 |
| Bretan, P; Paul, G; Sharma, J | 2 |
| Li, DX; Xuan, B; Zhou, J | 1 |
| Abd-el-Fattah, AA; Seif-el-Nasr, M; Shaheen, AA | 1 |
| Prillaman, HM; Turner, TT | 1 |
| Abboud, FM; Bielefeldt, K; Conklin, JL; Sharma, RV; Whiteis, CA | 1 |
| Cvetković, T; Kocić, G; Kocić, R; Pavlović, D; Stojanović, I; Vlahović, P | 1 |
| de Paola, AA; Fenelon, G; Franco, M; Katchburian, E; Mora, O | 1 |
| Bakir, K; Erbagci, A; Erturhan, S; Sarica, K; Uçak, R; Yağci, F | 1 |
| Burlando, B; Viarengo, A | 1 |
| Devecí, E | 1 |
| Nguyen, M; Sun, L; Wilson, DM; Yeh, LT; Zhou, D | 1 |
1 review(s) available for verapamil and allopurinol
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
53 other study(ies) available for verapamil and allopurinol
| Article | Year |
|---|---|
QSAR model for drug human oral bioavailability.
Topics: Administration, Oral; Biological Availability; Humans; Models, Biological; Models, Molecular; Pharmaceutical Preparations; Pharmacokinetics; Structure-Activity Relationship | 2000 |
Prediction of human volume of distribution values for neutral and basic drugs. 2. Extended data set and leave-class-out statistics.
Topics: Algorithms; Blood Proteins; Half-Life; Humans; Hydrogen-Ion Concentration; Models, Biological; Pharmaceutical Preparations; Pharmacokinetics; Protein Binding; Statistics as Topic; Tissue Distribution | 2004 |
Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling.
Topics: Adverse Drug Reaction Reporting Systems; Artificial Intelligence; Computers; Databases, Factual; Drug Prescriptions; Drug-Related Side Effects and Adverse Reactions; Endpoint Determination; Models, Molecular; Quantitative Structure-Activity Relationship; Software; United States; United States Food and Drug Administration | 2004 |
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
Structural requirements for drug inhibition of the liver specific human organic cation transport protein 1.
Topics: Cell Line; Computer Simulation; Drug Design; Gene Expression Profiling; Humans; Hydrogen Bonding; Liver; Molecular Weight; Organic Cation Transporter 1; Pharmaceutical Preparations; Predictive Value of Tests; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Structure-Activity Relationship | 2008 |
Physicochemical determinants of human renal clearance.
Topics: Humans; Hydrogen Bonding; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Kidney; Metabolic Clearance Rate; Molecular Weight | 2009 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Physicochemical space for optimum oral bioavailability: contribution of human intestinal absorption and first-pass elimination.
Topics: Administration, Oral; Biological Availability; Humans; Intestinal Absorption; Pharmaceutical Preparations | 2010 |
Multi-target spectral moment QSAR versus ANN for antiparasitic drugs against different parasite species.
Topics: Antiparasitic Agents; Molecular Structure; Neural Networks, Computer; Parasitic Diseases; Quantitative Structure-Activity Relationship; Species Specificity; Thermodynamics | 2010 |
FDA-approved drug labeling for the study of drug-induced liver injury.
Topics: Animals; Benchmarking; Biomarkers, Pharmacological; Chemical and Drug Induced Liver Injury; Drug Design; Drug Labeling; Drug-Related Side Effects and Adverse Reactions; Humans; Pharmaceutical Preparations; Reproducibility of Results; United States; United States Food and Drug Administration | 2011 |
Classification of inhibitors of hepatic organic anion transporting polypeptides (OATPs): influence of protein expression on drug-drug interactions.
Topics: Atorvastatin; Biological Transport; Drug Interactions; Estradiol; Estrone; HEK293 Cells; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; In Vitro Techniques; Least-Squares Analysis; Liver; Liver-Specific Organic Anion Transporter 1; Models, Molecular; Multivariate Analysis; Organic Anion Transporters; Organic Anion Transporters, Sodium-Independent; Protein Isoforms; Pyrroles; Solute Carrier Organic Anion Transporter Family Member 1B3; Structure-Activity Relationship; Transfection | 2012 |
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests | 2013 |
Evaluation of the effects of felodipine, verapamil and hydralazine on the survival rate of rats subjected to lethal effects of oxygen free radicals.
Topics: Animals; Blood Pressure; Creatine Kinase; Felodipine; Heart Rate; Hydralazine; Male; Rats; Rats, Sprague-Dawley; Superoxide Dismutase; Survival Rate; Verapamil; Xanthine; Xanthine Oxidase; Xanthines | 1992 |
Loss of mitochondrial respiratory function and its suppression during cold ischemic preservation of rat livers with University of Wisconsin solution.
Topics: Adenosine; Allopurinol; Animals; Chlorpromazine; Cryopreservation; Fatty Acids, Nonesterified; Glutathione; Insulin; Liver; Male; Mitochondria, Liver; Oligomycins; Organ Preservation; Organ Preservation Solutions; Oxygen Consumption; Raffinose; Rats; Rats, Inbred Strains; Serum Albumin, Bovine; Solutions; Time Factors; Verapamil | 1992 |
Acute renal failure following hemorrhagic shock: protective and aggravating factors.
Topics: Acute Kidney Injury; Allopurinol; Animals; Calcium; Dehydration; Free Radicals; Gentamicins; Kidney; Kidney Function Tests; Male; Rats; Rats, Inbred Strains; Reperfusion Injury; Shock, Hemorrhagic; Verapamil | 1992 |
Drugs effects on superoxide generation and chemiluminescence response of human leukocytes.
Topics: Catechin; Dipyridamole; Ditiocarb; Humans; Hypoxanthine; Hypoxanthines; Leukocytes; Luminescent Measurements; Luminol; Opsonin Proteins; Saccharomyces cerevisiae; Superoxides; Verapamil; Xanthine Oxidase | 1991 |
Reactive oxygen-mediated contraction in pulmonary arterial smooth muscle: cellular mechanisms.
Topics: 1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine; Adrenergic alpha-Antagonists; Adrenergic beta-Antagonists; Animals; In Vitro Techniques; Isoquinolines; Male; Muscle Contraction; Muscle, Smooth, Vascular; Norepinephrine; Oxygen; Phentolamine; Piperazines; Propranolol; Pulmonary Artery; Rats; Rats, Inbred Strains; Tetradecanoylphorbol Acetate; Verapamil; Xanthine Oxidase | 1991 |
Improved liver preservation for transplantation due to calcium channel blockade.
Topics: 3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl ester; Adenosine; Allopurinol; Animals; Calcium Channel Blockers; Glutathione; Insulin; Liver; Liver Transplantation; Nifedipine; Organ Preservation; Organ Preservation Solutions; Rabbits; Raffinose; Solutions; Verapamil | 1991 |
Effects of hypoxia and reoxygenation on the conversion of xanthine dehydrogenase to oxidase in Chinese hamster V79 cells.
Topics: Allopurinol; Animals; Calcium; Cell Line; Cell Membrane; Cricetinae; Cricetulus; Glucose; Hypoxia; Leupeptins; Lipid Peroxidation; Verapamil; Xanthine Dehydrogenase; Xanthine Oxidase | 1991 |
Verapamil improves rat hepatic preservation with UW solution.
Topics: Adenosine; Allopurinol; Animals; Glutathione; Insulin; Liver; Liver Circulation; Male; Organ Preservation; Organ Preservation Solutions; Raffinose; Rats; Rats, Inbred Strains; Solutions; Tissue Preservation; Verapamil | 1991 |
Does verapamil limit myocardial infarct size in a heart deficient in xanthine oxidase?
Topics: Animals; Blood Pressure; Male; Myocardial Infarction; Myocardium; Rabbits; Time Factors; Verapamil; Xanthine Oxidase | 1990 |
Effect of verapamil on conversion of xanthine dehydrogenase to oxidase in ischemic rat liver.
Topics: Animals; Calcium; Free Radicals; In Vitro Techniques; Ischemia; Liver; Male; Oxygen; Rats; Rats, Inbred Strains; Reperfusion Injury; Verapamil; Xanthine Dehydrogenase; Xanthine Oxidase | 1990 |
Ultrastructural changes in rat lungs after 48 h cold storage with and without reperfusion.
Topics: Allopurinol; Animals; Basement Membrane; Cryopreservation; Deferoxamine; Endothelium, Vascular; Epoprostenol; Lung; Lung Transplantation; Microscopy, Electron; Nifedipine; Organ Preservation; Rats; Rats, Inbred Strains; Reperfusion Injury; Time Factors; Verapamil | 1990 |
Tumor necrosis factor is a terminal mediator in galactosamine/endotoxin-induced hepatitis in mice.
Topics: Allopurinol; Animals; Chemical and Drug Induced Liver Injury; Eicosanoic Acids; Endotoxins; Epoprostenol; Galactosamine; Iloprost; Imidazoles; Male; Mice; Mice, Inbred Strains; Nifedipine; Superoxide Dismutase; Tumor Necrosis Factor-alpha; Verapamil; Xanthine Oxidase | 1989 |
Influence of allopurinol plus verapamil treatment on myocardial tissue necrosis during permanent coronary occlusion in canine hearts with small infarcts.
Topics: Allopurinol; Animals; Calcium; Coronary Circulation; Dogs; Free Radicals; Hemodynamics; Male; Myocardial Infarction; Myocardium; Necrosis; Oxygen Consumption; Verapamil | 1989 |
A novel mechanism for the generation of superoxide anions in hematoporphyrin derivative-mediated cutaneous photosensitization. Activation of the xanthine oxidase pathway.
Topics: Allopurinol; Animals; Cyclic N-Oxides; Dihematoporphyrin Ether; Electron Spin Resonance Spectroscopy; Female; Free Radicals; Hematoporphyrins; Mice; Mice, Inbred C3H; Oxygen; Photosensitivity Disorders; Premedication; Skin; Superoxides; Trypsin Inhibitors; Verapamil; Xanthine Oxidase | 1989 |
The influence of calcium channel blockers on superoxide anions.
Topics: Animals; Anions; Calcium Channel Blockers; Diltiazem; Fendiline; Free Radicals; In Vitro Techniques; Microsomes, Liver; Nifedipine; Oxidation-Reduction; Rats; Superoxides; Verapamil; Xanthine Oxidase | 1988 |
Effect of pharmacologic agents on the function of the hypothermically preserved dog kidney during normothermic reperfusion.
Topics: Allopurinol; Animals; Ca(2+) Mg(2+)-ATPase; Calcium-Transporting ATPases; Catalase; Cold Temperature; Deferoxamine; Dogs; Free Radicals; Glomerular Filtration Rate; Glutathione; In Vitro Techniques; Kidney; Kidney Transplantation; Organ Preservation; Oxygen; Perfusion; Proteinuria; Sodium; Superoxide Dismutase; Time Factors; Urine; Verapamil | 1988 |
Protection of cardiac membrane phospholipid against oxidative injury by calcium antagonists.
Topics: Animals; Calcium; Calcium Channel Blockers; Diltiazem; Heart; In Vitro Techniques; Lipid Peroxides; Male; Membrane Lipids; Myocardium; Nifedipine; Phospholipids; Rats; Verapamil; Xanthine Oxidase | 1988 |
Limitation of infarct size for 24 hours by combined treatment with allopurinol plus verapamil during acute myocardial infarction in the dog.
Topics: Allopurinol; Animals; Coronary Circulation; Disease Models, Animal; Dogs; Drug Evaluation, Preclinical; Drug Therapy, Combination; Male; Myocardial Infarction; Myocardium; Risk; Time Factors; Verapamil | 1987 |
Tissue protection by allopurinol in the myocardial calcium paradox.
Topics: Adenosine Triphosphate; Allopurinol; Animals; Calcium; Creatine Kinase; In Vitro Techniques; Male; Myocardium; Phosphocreatine; Rats; Rats, Inbred Strains; Verapamil | 1987 |
[Inhibition of adenosine uptake and stimulation of its effect on isolated hearts of warm-blooded animals by coronary active substances].
Topics: Alkaloids; Allopurinol; Animals; Carbon Isotopes; Cocaine; Depression, Chemical; Dipyridamole; Drug Synergism; Ethylenediamines; Guinea Pigs; Heart Rate; In Vitro Techniques; Myocardium; Nitroglycerin; Nucleosides; Ouabain; Papaverine; Prenylamine; Probenecid; Pyridines; Reserpine; Stimulation, Chemical; Theophylline; Triamterene; Vasodilator Agents; Verapamil | 1969 |
Myocardial infarct size limitation. Principles, problems and possibilities.
Topics: Allopurinol; Animals; Coronary Circulation; Dogs; Flurbiprofen; Humans; Metoprolol; Myocardial Infarction; Nifedipine; Tetrazolium Salts; Verapamil | 1984 |
Prevention of calcium influx does not inhibit endothelin release.
Topics: Allopurinol; Animals; Calcium; Endothelins; Female; In Vitro Techniques; Ischemia; Malondialdehyde; Mesenteric Artery, Superior; Muscle, Smooth, Vascular; Rats; Rats, Sprague-Dawley; Thiobarbituric Acid Reactive Substances; Verapamil | 1995 |
Cytoprotective effects of a stable prostacyclin analog and a calcium channel blocker: a study on isolated rat hepatocytes.
Topics: Adenosine; Allopurinol; Animals; Calcium Channel Blockers; Cell Survival; Cells, Cultured; Cryoprotective Agents; Female; Glutathione; Iloprost; Insulin; L-Lactate Dehydrogenase; Liver; Malondialdehyde; Organ Preservation Solutions; Raffinose; Rats; Rats, Wistar; Tissue Preservation; Verapamil | 1995 |
Enhancement of fluorescein perfusion in experimental skin flaps following postischemic washout with iloprost, urokinase, verapamil, and University of Wisconsin solution.
Topics: Adenosine; Allopurinol; Animals; Female; Fluorescein; Fluoresceins; Glutathione; Iloprost; Insulin; Ischemia; Organ Preservation Solutions; Perfusion; Raffinose; Rats; Rats, Sprague-Dawley; Skin; Surgical Flaps; Tissue Preservation; Urokinase-Type Plasminogen Activator; Verapamil | 1993 |
Lipid peroxidation and survival in rats following cerebral post-ischaemic reperfusion: effect of drugs with different molecular mechanisms.
Topics: Allopurinol; Animals; Antioxidants; Brain Ischemia; Deferoxamine; Diltiazem; Lipid Peroxidation; Male; Rats; Rats, Wistar; Reperfusion; Reperfusion Injury; Verapamil; Vitamin E | 1994 |
31P nuclear magnetic resonance spectroscopic evaluation of liver preservation solutions.
Topics: Acetylcysteine; Adenosine; Allopurinol; Animals; Antioxidants; Chromans; Glutathione; Insulin; Liver; Magnetic Resonance Spectroscopy; Male; Nucleotides; Organ Preservation; Organ Preservation Solutions; Perfusion; Raffinose; Rats; Rats, Sprague-Dawley; Verapamil | 1994 |
Effects of ischaemia and reperfusion on liver regeneration in rats.
Topics: Allopurinol; Animals; Female; Free Radicals; Hepatectomy; Ischemia; Lipid Peroxidation; Lipid Peroxides; Liver; Liver Regeneration; Rats; Rats, Sprague-Dawley; Reactive Oxygen Species; Reperfusion; Reperfusion Injury; Superoxide Dismutase; Verapamil | 1993 |
Effect of leukocyte adhesion and microvascular permeability on capillary perfusion during ischemia-reperfusion injury in hamster cheek pouch.
Topics: Adenosine; Allopurinol; Animals; Capillary Permeability; Cell Adhesion; Cheek; Cricetinae; Diltiazem; Leukocytes; Male; Mesocricetus; Perfusion; Pyrazoles; Reperfusion Injury; Verapamil | 1993 |
Rat small bowel preservation for 24 and 48 hours.
Topics: Adenosine; Allopurinol; Animals; Catalase; Free Radical Scavengers; Glutathione; Graft Survival; Hypertonic Solutions; Insulin; Intestine, Small; Male; Organ Preservation; Organ Preservation Solutions; Raffinose; Rats; Rats, Inbred Lew; Superoxide Dismutase; Time Factors; Verapamil | 1993 |
Improved renal preservation with PB-3 flush solution during 72 hours cold storage: demonstration of a salutary effect on isolated mitochondrial respiration.
Topics: Allopurinol; Animals; Cold Temperature; Dogs; Kidney; Kidney Transplantation; Kinetics; Mannitol; Mitochondria; Organ Preservation; Oxygen Consumption; Reperfusion Injury; Time Factors; Transplantation, Autologous; Verapamil | 1993 |
Effects of tetrahydroberberine on ischemic and reperfused myocardium in rats.
Topics: Animals; Anti-Arrhythmia Agents; Berberine; Berberine Alkaloids; In Vitro Techniques; Male; Malondialdehyde; Myocardial Ischemia; Myocardial Reperfusion Injury; Myocardium; Rats; Rats, Sprague-Dawley; Verapamil; Xanthine Oxidase | 1993 |
Influence of verapamil on the efficacy of vitamin E in preventing the ischemia-reperfusion-induced biochemical dearrangement in cerebral cortex of rat.
Topics: Animals; Calcium Channel Blockers; Cerebral Cortex; L-Lactate Dehydrogenase; Lipid Peroxidation; Male; Rats; Rats, Wistar; Reperfusion Injury; Verapamil; Vitamin E; Xanthine Dehydrogenase; Xanthine Oxidase | 1996 |
Rescue of testicular function after acute experimental torsion.
Topics: Allopurinol; Animals; Catalase; Male; Organ Size; Rats; Rats, Sprague-Dawley; Sperm Count; Spermatic Cord Torsion; Superoxide Dismutase; Testis; Testosterone; Time Factors; Verapamil | 1997 |
Reactive oxygen species and calcium homeostasis in cultured human intestinal smooth muscle cells.
Topics: Acetylcholine; Cadmium; Calcium; Calcium Channel Blockers; Cell Survival; Cells, Cultured; Homeostasis; Humans; Hydrogen Peroxide; Inositol 1,4,5-Trisphosphate; Intestines; Kinetics; Membrane Potentials; Muscle, Smooth; Nifedipine; Patch-Clamp Techniques; Potassium; Reactive Oxygen Species; Verapamil; Xanthine; Xanthine Oxidase; Xanthines | 1997 |
The possible importance of the cation-binding site for the oxidative modification of liver 5'-nucleotidase.
Topics: 5'-Nucleotidase; Animals; Binding Sites; Calcium Channel Blockers; Cations; Cells, Cultured; Free Radicals; Lipid Peroxidation; Liver; Male; Oxidation-Reduction; Oxidative Stress; Rats; Rats, Wistar; Verapamil; Xanthine; Xanthine Oxidase | 1998 |
Improved renal preservation with PB-3 flush solution during 72 h of cold storage.
Topics: Adenine Nucleotides; Adenosine; Allopurinol; Animals; Cold Temperature; Kidney; Male; Mannitol; Mitochondria; Organ Preservation; Organ Preservation Solutions; Oxidative Phosphorylation; Rats; Rats, Sprague-Dawley; Time Factors; Verapamil | 1994 |
Combined therapy with steroids and antioxidants prevents ultrastructural damage surrounding chronic radiofrequency lesions.
Topics: Allopurinol; Animals; Anti-Inflammatory Agents; Antioxidants; Catheter Ablation; Dogs; Drug Therapy, Combination; Heart Atria; Heart Ventricles; Hydrocortisone; Male; Prednisolone; Steroids; Verapamil; Wound Healing | 2004 |
Limitation of apoptotic changes in renal tubular cell injury induced by hyperoxaluria.
Topics: Allopurinol; Animals; Apoptosis; Cells, Cultured; Disease Models, Animal; Hyperoxaluria; In Situ Nick-End Labeling; Kidney Tubules; Male; Oxalates; Potassium Citrate; Rabbits; Random Allocation; Reference Values; Sensitivity and Specificity; Urinary Calculi; Urothelium; Verapamil; Vitamin E | 2004 |
Ca2+ is mobilized by hydroxyl radical but not by superoxide in RTH-149 cells: the oxidative switching-on of Ca2+ signaling.
Topics: Animals; Calcium Signaling; Carcinoma, Hepatocellular; Cell Line, Tumor; Estrenes; Fluorescent Dyes; Hydroxyl Radical; Hypoxanthine; Oxidants; Oxidation-Reduction; Pyrrolidinones; Rhodamines; Superoxides; Trout; Verapamil; Xanthine Oxidase | 2005 |
Role of allopurinol, verapamil, dexamethasone and trifluoperazine as prophylactic agents in intestinal ischemia-reperfusion.
Topics: Allopurinol; Animals; Dexamethasone; Intestine, Small; Male; Rats; Rats, Wistar; Reperfusion Injury; Trifluoperazine; Verapamil | 2008 |
The Effects of Special Patient Population Plasma on Pharmacokinetic Quantifications Using LC-MS/MS.
Topics: Allopurinol; Calibration; Chromatography, High Pressure Liquid; Clinical Trials as Topic; Hepatic Insufficiency; Humans; Kidney; Liver; Oxypurinol; Reference Standards; Renal Insufficiency; Renal Reabsorption; Reproducibility of Results; Tandem Mass Spectrometry; Thioglycolates; Triazoles; Uricosuric Agents; Verapamil | 2019 |